Drugmakers Reminded Of Production Rules

Malaysia's Drug Control Authority (DCA) has reminded pharmaceutical companies to inform it of changes to their production processes. Failure to do so will result in the cancellation of licences and withdrawal of products. It is BMI's view that this development underlines the steady evolution of the DCA. Standards employed by the regulatory body are now approaching international

To read the full article, please choose one of the following options: